EntryPoint Capital LLC Has $246,000 Position in Enhabit, Inc. (NYSE:EHAB)

EntryPoint Capital LLC lessened its holdings in Enhabit, Inc. (NYSE:EHABFree Report) by 3.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 31,506 shares of the company’s stock after selling 1,245 shares during the period. EntryPoint Capital LLC’s holdings in Enhabit were worth $246,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of EHAB. FMR LLC lifted its stake in Enhabit by 138.4% in the 3rd quarter. FMR LLC now owns 3,388 shares of the company’s stock worth $27,000 after acquiring an additional 1,967 shares in the last quarter. Quantbot Technologies LP acquired a new stake in shares of Enhabit during the fourth quarter worth approximately $45,000. Corient Private Wealth LLC purchased a new position in Enhabit during the fourth quarter valued at approximately $79,000. Intech Investment Management LLC acquired a new position in Enhabit in the 3rd quarter valued at approximately $96,000. Finally, Stoneridge Investment Partners LLC lifted its position in Enhabit by 22.6% in the 4th quarter. Stoneridge Investment Partners LLC now owns 12,533 shares of the company’s stock worth $98,000 after buying an additional 2,308 shares in the last quarter.

Analysts Set New Price Targets

Separately, Jefferies Financial Group reaffirmed a “buy” rating on shares of Enhabit in a research note on Thursday, March 6th.

Check Out Our Latest Stock Analysis on Enhabit

Enhabit Trading Down 3.2 %

NYSE:EHAB opened at $8.64 on Friday. The company has a market capitalization of $436.35 million, a P/E ratio of -3.73 and a beta of 1.80. The stock’s 50 day moving average price is $8.52 and its 200 day moving average price is $7.98. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46. Enhabit, Inc. has a 52 week low of $6.85 and a 52 week high of $11.69.

Enhabit Company Profile

(Free Report)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Read More

Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHABFree Report).

Institutional Ownership by Quarter for Enhabit (NYSE:EHAB)

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.